Treating hepatitis B in HIV patients can reduce risk of primary liver cancer, Penn Medicine study finds
The study found that patients with both HIV and hepatitis B had a two-fold increase in primary liver cancer and that treatment of hepatitis B reduced that risk by 58%.



















